(Q38526067)

3 September 2017

title

Effect of pentoxifylline on radiation response of non-small cell lung cancer: a phase III randomized multicenter trial (English)

1 reference

multicenter clinical trial

3 September 2017

main subject

phase III clinical trial

0 references

0 references

1 reference

Kwon HC

1

1 reference

3 September 2017

Kim SK

2

1 reference

3 September 2017

Chung WK

3

1 reference

3 September 2017

Cho MJ

4

1 reference

3 September 2017

Kim JS

5

1 reference

3 September 2017

Kim JS

6

1 reference

3 September 2017

Moon SR

7

1 reference

3 September 2017

Park WY

8

1 reference

3 September 2017

Ahn SJ

9

1 reference

3 September 2017

Oh YK

10

1 reference

3 September 2017

Yun HG

11

1 reference

3 September 2017

Na BS

12

1 reference

3 September 2017

publication date

1 August 2000

1 reference

Radiotherapy and Oncology

3 September 2017

published in

1 reference

3 September 2017

volume

56

1 reference

3 September 2017

issue

2

1 reference

3 September 2017

page(s)

175-179

1 reference

Keynote address: hypoxic cell radiosensitizers: where next?

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900221-8

7 January 2021

The effect of pentoxifylline on early and late radiation injury following fractionated irradiation in C3H mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900221-8

7 January 2021

Pentoxifylline: its pharmacokinetics and ability to improve tumour perfusion and radiosensitivity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900221-8

7 January 2021

Enhancement of radiation response on human carcinoma cells in culture by pentoxifylline

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900221-8

7 January 2021

Effect of pentoxifylline on radiation-induced lung and skin toxicity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900221-8

7 January 2021

Changes in tumour blood flow, oxygenation and interstitial fluid pressure induced by pentoxifylline

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900221-8

7 January 2021

Increases in tumor response by pentoxifylline alone or in combination with nicotinamide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900221-8

7 January 2021

The effect of pentoxifylline on red cell deformability in cerebrovascular accidents

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900221-8

7 January 2021

Haemorheology and cerebrovascular disease: multifunctional approach with pentoxifylline

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900221-8

7 January 2021

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900221-8

7 January 2021

Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900221-8

7 January 2021

Preferential radiosensitization of G1 checkpoint-deficient cells by methylxanthines.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900221-8

7 January 2021

Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900221-8

7 January 2021

10.1016/S0167-8140(00)00221-8

Identifiers

DOI

1 reference

3 September 2017

1 reference